| abstract |
The present invention encompasses compounds of general formula (1) wherein the groups R 1 to R 5 are defined as in claim 1 , which are suitable for treating diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties. |